1968
Eisai Co, Ltd started marketing operations in Indonesia
PT Eisai Indonesia's career began in 1968, starting with Eisai Co., Ltd which started marketing operations in Indonesia. Eisai started its business by focusing on the health of patients and their families. Continues to grow and expand in Indonesia until now PT Eisai Indonesia has been contributing to the health of the Indonesian people for more than 50 years.
Eisai Co, Ltd started marketing operations in Indonesia
PT Eisai Indonesia (PTEI) established and approved by the President of the Republic of Indonesia
Kebun Pertjobaan Tjianjur was inaugurated by the Indonesian Minister of Health.
KPT published 1st Edition Book of Medicinal Herbs Index
Message from CEO Yuji Naito (2nd generation of Naito`s family) written Think Positive. CEO Naito sharing that Eisai member have to think positive during their activity.
PTEI Factory moved to Citeureup, Bogor, and was inaugurated by the Ministry of Health of the Republic of Indonesia.
Exported medicine to Japan for the first time
Expanded the export of medicine to Thailand.
Obtained GMP Certificates and Certificate of Analyses of Environmental Impacts.
Innovation Medicine for treatment to Alzheimer's Disease, launched as Eisai Global Product
Novel Medicine for treatment to Gastroentherology, launched as Eisai Global Product
Bogor Factory was awarded “Zero Accident Award” by Ministry of Manpower and Transmigration of Republic of Indonesia.
For the second time, Bogor Factory was awarded “Zero Accident Award” by Ministry of Manpower and Transmigration of Republic of Indonesia. Bogor Factory was awarded “Environment Conservation Award” by Bogor government.
1st Eisai Global Oncology product for Metastatic Breast Cncer (MBC) was launched
2nd Eisai Global Oncology Product for Differentiated Thyroid Cancer (DTC) launched as Eisai Global Product
New indication for 2nd Eisai Global Oncology product as Hepato Cellular Carcinoma (HCC) launched
The latest Halal Certification for PTEI factory was approved by Indonesia's Ministry of religion
1st Eisai global product on Dual Orexin Receptor Antagonist (DORA) indicated
for the treatment of insomnia was launched
The worlds 1st IBAT Inhibitor which uses the Dual Action of Bile Acids as Physiological Laxative for Chronic Constipation